Company Details
biomerieux
12,724
371,268
541714
biomerieux.com
174
BIO_1694400
Completed

bioMérieux Company CyberSecurity Posture
biomerieux.comA family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.
Company Details
biomerieux
12,724
371,268
541714
biomerieux.com
174
BIO_1694400
Completed
Between 750 and 799

bioMérieux Global Score (TPRM)XXXX

Description: The bioMérieux company reported a data breach involving its vendor, Vitality Group, on June 28, 2023. The breach occurred due to unauthorized access to personal information through a vulnerability in the MOVEit Transfer application on June 1, 2023, affecting social security numbers, health information, and personal details of members. The number of individuals affected is currently unknown.


No incidents recorded for bioMérieux in 2025.
No incidents recorded for bioMérieux in 2025.
No incidents recorded for bioMérieux in 2025.
bioMérieux cyber incidents detection timeline including parent company and subsidiaries

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals w
Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development an

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to eac

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research,
CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our pr

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness an
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product
.png)
Jones Day recently hosted a webinar in which trade secrets lawyers provided tips for protecting trade secrets from today's threats.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of bioMérieux is https://www.biomerieux.com.
According to Rankiteo, bioMérieux’s AI-generated cybersecurity score is 789, reflecting their Fair security posture.
According to Rankiteo, bioMérieux currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, bioMérieux is not certified under SOC 2 Type 1.
According to Rankiteo, bioMérieux does not hold a SOC 2 Type 2 certification.
According to Rankiteo, bioMérieux is not listed as GDPR compliant.
According to Rankiteo, bioMérieux does not currently maintain PCI DSS compliance.
According to Rankiteo, bioMérieux is not compliant with HIPAA regulations.
According to Rankiteo,bioMérieux is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
bioMérieux operates primarily in the Biotechnology Research industry.
bioMérieux employs approximately 12,724 people worldwide.
bioMérieux presently has no subsidiaries across any sectors.
bioMérieux’s official LinkedIn profile has approximately 371,268 followers.
bioMérieux is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).
No, bioMérieux does not have a profile on Crunchbase.
Yes, bioMérieux maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/biomerieux.
As of December 11, 2025, Rankiteo reports that bioMérieux has experienced 1 cybersecurity incidents.
bioMérieux has an estimated 4,470 peer or competitor companies worldwide.
Incident Types: The types of cybersecurity incidents that have occurred include Vulnerability.
Title: bioMérieux Data Breach
Description: The bioMérieux company reported a data breach involving its vendor, Vitality Group, on June 28, 2023. The breach occurred due to unauthorized access to personal information through a vulnerability in the MOVEit Transfer application on June 1, 2023, affecting social security numbers, health information, and personal details of members. The number of individuals affected is currently unknown.
Date Detected: 2023-06-01
Date Publicly Disclosed: 2023-06-28
Type: Data Breach
Attack Vector: Unauthorized Access
Vulnerability Exploited: MOVEit Transfer application vulnerability
Common Attack Types: The most common types of attacks the company has faced is Vulnerability.

Data Compromised: Social security numbers, Health information, Personal details
Commonly Compromised Data Types: The types of data most commonly compromised in incidents are Social Security Numbers, Health Information, Personal Details and .

Type of Data Compromised: Social security numbers, Health information, Personal details

Source: bioMérieux
Additional Resources: Stakeholders can find additional resources on cybersecurity best practices at and Source: bioMérieux.
Most Recent Incident Detected: The most recent incident detected was on 2023-06-01.
Most Recent Incident Publicly Disclosed: The most recent incident publicly disclosed was on 2023-06-28.
Most Significant Data Compromised: The most significant data compromised in an incident were Social Security Numbers, Health Information, Personal Details and .
Most Sensitive Data Compromised: The most sensitive data compromised in a breach were Health Information, Social Security Numbers and Personal Details.
Most Recent Source: The most recent source of information about an incident is bioMérieux.
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.